These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35701724)

  • 1. Remdesivir-induced bradycardia in a 26-year-old patient with COVID-19: a case report.
    Guziejko K; Talalaj J; Chorazy M; Groth M; Moniuszko-Malinowska A
    Infection; 2022 Dec; 50(6):1605-1613. PubMed ID: 35701724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remdesivir-associated bradycardia.
    Ching PR; Lee C
    BMJ Case Rep; 2021 Sep; 14(9):. PubMed ID: 34479903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sinus Bradycardia in a Pediatric Patient Treated With Remdesivir for Acute Coronavirus Disease 2019: A Case Report and a Review of the Literature.
    Chow EJ; Maust B; Kazmier KM; Stokes C
    J Pediatric Infect Dis Soc; 2021 Oct; 10(9):926-929. PubMed ID: 34173663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Remdesivir use with bradycardia: A systematic review and meta-analysis.
    Ishisaka Y; Aikawa T; Malik A; Kampaktsis PN; Briasoulis A; Kuno T
    J Med Virol; 2023 Aug; 95(8):e29018. PubMed ID: 37539782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Characteristics and Implications of Bradycardia in COVID-19 Patients Treated with Remdesivir: A Single-Center Retrospective Cohort Study.
    Schreiber A; Bauzon JS; Batra K; Mohammed S; Lee K; Houshmand N; Pham U; Cosme C; Inciong K; Al-Taweel O; Nasser K; Rana J; Sossou C; Go A; Hawwass D; Diep J; Ahsan CH
    Clin Drug Investig; 2022 Sep; 42(9):763-774. PubMed ID: 35978159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and heart rate changes in Covid-19 patients treated with Remdesivir.
    Brunetti ND; Poliseno M; Bottalico IF; Centola A; Montemurro L; Sica S; Santantonio T; Lo Caputo S
    Int J Infect Dis; 2021 Nov; 112():254-257. PubMed ID: 34551344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient asymptomatic bradycardia and remdesivir in COVID-19 patients.
    Adamo G; Amata M; Cannizzaro N; Chessari C; Sapienza GM; Capizzi GM; Battaglia S; Benfante A; Scichilone N
    Minerva Med; 2023 Aug; 114(4):463-468. PubMed ID: 35332758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remdesivir Use in Pediatric Patients for SARS-CoV-2 Treatment: Single Academic Center Study.
    Samuel AM; Hacker LL; Zebracki J; Bogenschutz MC; Schulz L; Strayer J; Vanderloo JP; Cengiz P; Henderson S
    Pediatr Infect Dis J; 2023 Apr; 42(4):310-314. PubMed ID: 36728726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remdesivir-Related Cardiac Adverse Effects in COVID-19 Patients: A Case-Control Study.
    Abedipour F; Mirzaei HH; Ansari H; Ehsanzadeh N; Rashki A; Vahedi MM; Rashki A
    Drug Res (Stuttg); 2024 Jul; 74(6):290-295. PubMed ID: 38968952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remdesivir-induced bradycardia in patients hospitalized with SARS-CoV2 infection: a possible vagally-mediated mechanism.
    Filtz A; Carandina A; Fasiello A; Barbetta L; Lombardi R; Cinque F; Rizzi G; Ceriani E; Furlan L; Bellocchi C; Fracanzani AL; Hu C; Cogliati C; Canetta C; Peyvandi F; Montano N; Tobaldini E
    Intern Emerg Med; 2023 Mar; 18(2):359-366. PubMed ID: 36539604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case Report: Severe SARS-CoV-2 Infection Treated with Remdesivir in a Patient with ESRD.
    Patel RH; Pella PM; Haider N; Blanco R
    Infect Disord Drug Targets; 2022; 22(3):e011221198456. PubMed ID: 34852751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.
    Wang Y; Zhang D; Du G; Du R; Zhao J; Jin Y; Fu S; Gao L; Cheng Z; Lu Q; Hu Y; Luo G; Wang K; Lu Y; Li H; Wang S; Ruan S; Yang C; Mei C; Wang Y; Ding D; Wu F; Tang X; Ye X; Ye Y; Liu B; Yang J; Yin W; Wang A; Fan G; Zhou F; Liu Z; Gu X; Xu J; Shang L; Zhang Y; Cao L; Guo T; Wan Y; Qin H; Jiang Y; Jaki T; Hayden FG; Horby PW; Cao B; Wang C
    Lancet; 2020 May; 395(10236):1569-1578. PubMed ID: 32423584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remdesivir-induced Bradycardia is not Associated with Worse Outcome in Patients with COVID-19: A Retrospective Analysis.
    Pantazopoulos I; Mavrovounis G; Dimeas G; Zikos N; Pitsikou M; Rousogianni E; Mermiri M; Michou A; Spanos M; Maniotis C; Chalkias A; Laou E; Zakynthinos G; Chatzis D; Gourgoulianis K
    Am J Cardiovasc Drugs; 2022 Nov; 22(6):705-710. PubMed ID: 36002783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remdesivir-Induced Marked Sinus Bradycardia in COVID-19.
    Ahmed T; Lodhi SH; Ahmed T
    Cureus; 2022 Jul; 14(7):e27249. PubMed ID: 36035063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precipitating factors of bradycardia after remdesivir administration: ICU admission and cutoff value for declining heart rate.
    Chen YZ; Lin MS; Lin YP; Liu YZ; Yang CJ
    J Microbiol Immunol Infect; 2023 Oct; 56(5):970-976. PubMed ID: 37407291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remdesivir associated sinus bradycardia in patients with COVID-19: A prospective longitudinal study.
    Hajimoradi M; Sharif Kashani B; Dastan F; Aghdasi S; Abedini A; Naghashzadeh F; Mohamadifar A; Keshmiri MS; Noorali S; Lookzadeh S; Alizadeh N; Siri MA; Tavasolpanahi M; Abdolmohammadi Y; Shafaghi M; Rouhani ZS; Shafaghi S
    Front Pharmacol; 2022; 13():1107198. PubMed ID: 36733376
    [No Abstract]   [Full Text] [Related]  

  • 17. Remdesivir treatment and clinical outcome in non-severe hospitalized COVID-19 patients: a propensity score matching multicenter Italian hospital experience.
    Attena E; Caturano A; Annunziata A; Maraolo AE; De Rosa A; Fusco FM; Halasz G; Dall'Ospedale V; Conte M; Parisi V; Galiero R; Sasso FC; Fiorentino G; Russo V
    Eur J Clin Pharmacol; 2023 Jul; 79(7):967-974. PubMed ID: 37212843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nirmatrelvir-remdesivir association for non-hospitalized adults with COVID-19, point of view.
    Ferrara F; Zovi A; Trama U; Vitiello A
    Inflammopharmacology; 2022 Oct; 30(5):1927-1931. PubMed ID: 35980509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bradycardia associated with remdesivir therapy for COVID-19 in a 59-year-old man.
    Day LB; Abdel-Qadir H; Fralick M
    CMAJ; 2021 Apr; 193(17):E612-E615. PubMed ID: 33903133
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessment of adverse events associated with remdesivir use for coronavirus disease 2019 using real-world data.
    Singh A; Kamath A
    Expert Opin Drug Saf; 2021 Dec; 20(12):1559-1564. PubMed ID: 34328807
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.